UTSW researchers neutralize genetic risk factor found in 50 to 80 percent of human cases
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Apolipoprotein E (ApoE) is a protein that carries fatty substances called lipids and cholesterol around the brain and plays an important role in repair mechanisms. There are three major forms of ApoE (i.e., ApoE2, ApoE3, and ApoE4); individuals who carry ApoE4 are up to 10 times more likely to develop Alzheimer’s than those with ApoE2 and ApoE3 forms. ApoE4 promotes accumulation of the b-amyloid protein that causes the characteristic plaques seen in the brains of Alzheimer’s patients.
UT Southwestern molecular biologist and Alzheimer’s expert Dr. Joachim Herz, lead author of the study, which was published in the November issue of eLife said the goal of his team is to prevent the disease from ever manifesting. Late-onset Alzheimer’s generally is diagnosed about age 65 and is the most common cause of dementia in the elderly. “If we can negate the ApoE4 process early, we may be able to prevent late-onset Alzheimer’s altogether for many people so that they will never get sick,” Dr. Herz said.
ApoE4 has been shown to suppress and trap synaptic receptors within intracellular vesicles. However, how the ApoE4 gets trapped has remained a mystery until now. According to Dr. Herz, ApoE4 is the root cause of a “traffic jam” inside the cells that take up ApoE4 and this is associated with reduced recycling of intracellular endosomal transport vesicles. UTSW researchers found that lowering the pH of these endosomes, i.e., by making them more acidic, cleared the traffic jam: The scientists were able to completely reverse the ApoE4-induced recycling block in mice through pharmacological and genetic inhibition of the NHE6 protein, which acts to make the endosomal vesicles less acidic.
These findings suggest a novel potential therapeutic approach for the prevention of late-onset Alzheimer’s disease, Dr. Herz said. The vesicle traffic jam due to the selective loss of solubility of ApoE4 likely is the earliest mechanism at which the protein negatively affects nerve cells, Dr. Herz said.
Most Alzheimer’s research has focused on halting the formation of amyloid and tau protein aggregates once they exist in the brain and degeneration has already begun. “Our approach in this study was to stop the overall degeneration process earlier; that is, before the formation of these aggregates,” Dr. Herz said.
The next step is to develop tailor-made, small molecule inhibitors that can enter the brain efficiently and selectively block NHE6, he added.
“The beauty of NHE inhibitors is that these are small molecules that can be produced inexpensively and thus made widely available, in contrast to the more elaborate antibody-based therapies that are currently being evaluated in clinical trials. A simple pill could someday neutralize the risk of late-onset Alzheimer’s disease just as readily available statins are able to reduce the risk of cardiovascular disease,” Dr. Herz said.
Learn more: Research suggests path to vaccine or drug for late-onset Alzheimer’s
The Latest on: Late-onset Alzheimer’s
[google_news title=”” keyword=”late-onset Alzheimer’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Late-onset Alzheimer’s
- Youth-Onset Diabetes Linked to Higher Alzheimer’s Riskon May 8, 2024 at 1:47 pm
The study discovered blood biomarkers and amyloid protein accumulations typical of AD in individuals diagnosed with diabetes during childhood or adolescence.
- Study seeks to explain why Sephardi Jews more likely to get early-onset Alzheimer’son May 8, 2024 at 12:24 pm
A new study funded by a grant of more than $13 million from the US National Institutes of Health will look into possible genetic reasons why Sephardic Jews are diagnosed with Alzheimer’s disease at ...
- Gene mutation may signal new genetic form of Alzheimer's diseaseon May 7, 2024 at 10:53 am
People who carry two copies of the gene mutation most strongly implicated in Alzheimer's disease are almost certain to develop brain changes related to the degenerative disorder, a new study says.
- Alzheimer’s Type Identified That Involves Gene Variant Carried by 2% of Populationon May 7, 2024 at 9:00 am
Scientists say findings have important implications for public health, genetic counseling of carriers, and future research directions.
- Alzheimer's by Age 65 Nearly Guaranteed for Carriers of Two Copies of APOE4on May 7, 2024 at 7:16 am
Humans carry a gene called APOE that encodes for a protein called apolipoprotein E. There are several variations of this gene. | Clinical And Molecular Dx ...
- Olive oil could help reduce risk of dying from dementia, Harvard study sayson May 6, 2024 at 12:58 pm
Consuming olive oil could help reduce the risk of dying from dementia, regardless of overall diet quality, a new study in U.S. adults suggests.
- APOE4 Gene Doubles Up Alzheimer’s Riskon May 6, 2024 at 11:57 am
These findings indicate that APOE4 homozygotes not only have a higher risk but also develop Alzheimer’s earlier than those with other gene variants, suggesting that APOE4 might be considered a ...
- Study identifies APOE4 homozygotes as high-risk group for Alzheimer's diseaseon May 6, 2024 at 11:37 am
Researchers from the Research Area on Neurological Diseases, Neuroscience, and Mental Health at the Sant Pau Research Institute, led by Dr. Juan Fortea, Director of the Memory Unit of the Neurology ...
- Study suggests genetics is underlying cause of some forms of Alzheimer'son May 6, 2024 at 11:19 am
Researchers writing in the journal Nature have identified a genetic form of late-onset Alzheimer's disease in people who inherit two copies of a worrisome gene.
- Some Alzheimer's cases may be caused by copies of a single gene, research showson May 6, 2024 at 10:59 am
Researchers have identified a genetic form of late-onset Alzheimer’s disease in people who inherit two copies of the APOE4 gene. The study marks a breakthrough.
via Bing News